医学
肺炎
脓胸
胸腔积液
社区获得性肺炎
重症监护医学
呼吸窘迫
肺炎链球菌
外科
类鼻疽
肺旁积液
抗生素
细菌性肺炎
内科学
病理
胸膜液
微生物学
生物
作者
Fernando Maria de Benedictis,Eitan Kerem,Anne B. Chang,Andrew A. Colin,Heather J. Zar,Andrew Bush
出处
期刊:The Lancet
[Elsevier]
日期:2020-09-01
卷期号:396 (10253): 786-798
被引量:170
标识
DOI:10.1016/s0140-6736(20)31550-6
摘要
Complicated community-acquired pneumonia in a previously well child is a severe illness characterised by combinations of local complications (eg, parapneumonic effusion, empyema, necrotising pneumonia, and lung abscess) and systemic complications (eg, bacteraemia, metastatic infection, multiorgan failure, acute respiratory distress syndrome, disseminated intravascular coagulation, and, rarely, death). Complicated community-acquired pneumonia should be suspected in any child with pneumonia not responding to appropriate antibiotic treatment within 48-72 h. Common causative organisms are Streptococcus pneumoniae and Staphylococcus aureus. Patients have initial imaging with chest radiography and ultrasound, which can also be used to assess the lung parenchyma, to identify pleural fluid; CT scanning is not usually indicated. Complicated pneumonia is treated with a prolonged course of intravenous antibiotics, and then oral antibiotics. The initial choice of antibiotic is guided by local microbiological knowledge and by subsequent positive cultures and molecular testing, including on pleural fluid if a drainage procedure is done. Information from pleural space imaging and drainage should guide the decision on whether to administer intrapleural fibrinolytics. Most patients are treated by drainage and more extensive surgery is rarely needed; in any event, in low-income and middle-income countries, resources for extensive surgeries are scarce. The clinical course of complicated community-acquired pneumonia can be prolonged, especially when patients have necrotising pneumonia, but complete recovery is the usual outcome.
科研通智能强力驱动
Strongly Powered by AbleSci AI